MedCity Pivot
Episode Summary Particle Health CEO Jason Prestinario joins MedCity Pivot to assess the state of U.S. healthcare interoperability with clear-eyed candor. He grades the technical infrastructure a B — data can move — but gives access governance a C, because the rules around who uses data, and how, remain murky and poorly enforced. Jason draws a direct line between true interoperability and the viability of value-based care: without frictionless data access, accountability for patient outcomes is impossible. The conversation also covers Particle's antitrust lawsuit against Epic, now past its...
info_outlineMedCity Pivot
Episode Summary In this episode of the MedCity Pivot Podcast, host Arundhati Parmar sits down with Javier Gonzalez (Abarca Health) and Tanvi Patel (Amazon Pharmacy) to unpack one of healthcare’s most frustrating processes: prior authorization. The conversation explores how outdated systems, lack of transparency, and fragmented communication are eroding patient trust and delaying care. From policy complexity and data gaps to operational risks, the guests break down why prior authorization remains such a challenge—and what it will take to modernize it at scale. They also highlight the...
info_outlineMedCity Pivot
Summary In this episode of the Med City Pivot Podcast, host Arundhati Parmar speaks with Lars Petersen about one of the most remarkable corporate transformations in modern business history. Facing a catastrophic collapse of its core film business in the mid-2000s due to the rise of digital photography, Fujifilm executed a bold and strategic pivot into healthcare and life sciences. The company diversified aggressively, leveraging its deep expertise in materials science, imaging, and innovation to build a thriving biotechnology and medical technology ecosystem. Today, Fujifilm operates as a...
info_outlineMedCity Pivot
EPISODE SUMMARY In this episode, Arundhati Parmar interviews Shalin Shah, CEO of Marius Pharmaceuticals, about Testosterone Replacement Therapy (TRT) and the long-standing regulatory classification that places testosterone as a Schedule III controlled substance. Shah explains that testosterone was scheduled in 1990 following Olympic doping scandals — despite opposition at the time from the FDA, DEA, and the American Medical Association. More than 30 years later, he argues that the regulatory framework no longer reflects current clinical evidence and may be doing more harm than good. The...
info_outlineMedCity Pivot
Summary Tune into MedCity Pivot Podcast with host Arundhati Parmar as three healthcare tech leaders—Serge Perras, Ton Roelandse, and Bertil Chappuis—decode AI's true potential in healthcare. Explore its role in enhancing efficiency and busting myths about AI supremacy. Episode Highlights 00:00:19 - The high bar for AI safety in healthcare. 00:01:29 - AI's current hype and exaggerated promises. 00:03:57 - Misconceptions about AI replacing healthcare roles. 00:05:51 - Meaningful AI use cases: Prior authorization automation. 00:06:52 - AI in triage and its capacity enhancements....
info_outlineMedCity Pivot
During the episode, MedCity News Associate Editor Katie Adams interviews Dr. Hamad Husainy, chief medical officer at PointClickCare, and Dr. Barbara Bond, a physician at Sutter Health, about how AI can help improve patient outcomes in the emergency department. Episode Resources Connect with Arundhati Parmar Review, Subscribe and Share If you like what you hear please leave a review by Make sure you’re subscribed to the podcast so you get the latest episodes.
info_outlineMedCity Pivot
I interviewed Adriana Ramirez and Matt Gibbs, and we spoke about how a new approach to pharmacy benefits management. Episode Resources Connect with Arundhati Parmar Connect with Adriana Ramirez and Matt Gibbs Review, Subscribe and Share If you like what you hear please leave a review by Make sure you’re subscribed to the podcast so you get the latest episodes.
info_outlineMedCity Pivot
I am interviewing Dr. Iftach Dolev, co-founder and CEO of QuantalX a neurodiagnostics company that has just received FDA clearance for its device. Episode Resources Connect with Arundhati Parmar Connect with Dr. Iftach Dolev Review, Subscribe and Share If you like what you hear please leave a review by Make sure you’re subscribed to the podcast so you get the latest episodes.
info_outlineMedCity Pivot
This episode was sponsored by Quantum Health. Katie Adams, associate editor at MedCity News, interviewed Shannon Skaggs, chief AI officer at Quantum Health, about how AI is reshaping the care navigation and benefits guidance world. Episode Resources Connect with Arundhati Parmar Connect with Shannon Skaggs Review, Subscribe and Share If you like what you hear please leave a review by Make sure you’re subscribed to the podcast so you get the latest episodes.
info_outlineMedCity Pivot
I interviewed Dr. Rowland Illing, Chief Medical Officer of AWS (Amazon Web Services) about its Health Data Lake and how those data are being powered into innovations transforming healthcare. Episode Resources Connect with Arundhati Parmar Connect with Rowland Illing Review, Subscribe and Share If you like what you hear please leave a review by Make sure you’re subscribed to the podcast so you get the latest episodes.
info_outlineEpisode Summary
Particle Health CEO Jason Prestinario joins MedCity Pivot to assess the state of U.S. healthcare interoperability with clear-eyed candor. He grades the technical infrastructure a B — data can move — but gives access governance a C, because the rules around who uses data, and how, remain murky and poorly enforced. Jason draws a direct line between true interoperability and the viability of value-based care: without frictionless data access, accountability for patient outcomes is impossible.
The conversation also covers Particle's antitrust lawsuit against Epic, now past its first major legal hurdle, and the broader wave of litigation challenging Epic's market dominance. Jason urges nuance: there's a meaningful difference between patients authorizing their own data use and bad actors harvesting records without consent — and conflating the two risks setting back the entire data-sharing ecosystem.
Key Takeaways
- The data infrastructure gets a B — but access governance is still a C. The technical pipes for moving health records exist, but who can use them, when, and for what purpose remains the critical unsolved problem.
- Interoperability is a 'nice to have' in fee-for-service care — but it's a hard requirement for value-based care. When a provider is accountable for outcomes that happen outside their four walls, they need data from outside those walls.
- Information blocking penalties need teeth. Until healthcare organizations believe violations will result in real consequences, the rules won't change behavior — just like speed limits only work when drivers believe tickets are real.
- There's a critical distinction between patients authorizing their own data use and third parties accessing data without consent. The current Epic lawsuit debate conflates two very different scenarios that deserve separate legal and regulatory treatment.
- True patient data ownership is still largely a myth. Despite portals and progress, patients still face significant barriers — forgotten logins, provider-controlled systems — to accessing their own medical records programmatically.
Links and Resources
- Connect with Arundhati Parmar
- aparmar@medcitynews.com
- Arundhati Parmar (@aparmarbb) on X
- MedCity News
Keywords
healthcare interoperability, Particle Health, Jason Prestinario, Epic lawsuit, antitrust healthcare, value-based care, CMS interoperability, TEFCA, Carequality, health data access, information blocking, 21st Century Cures Act, patient data ownership, HIPAA compliance, health information exchange, payer interoperability, digital health data, EHR data sharing, CommonWell, ONC rules
Episode Highlights
- [00:04:22 - 00:05:16] Jason grades the interoperability 'pipes' a B-plus but gives data access governance a C at best.
- [00:10:56 - 00:12:37] Interoperability shifts from 'nice to have' in fee-for-service to a hard requirement in value-based care.
- [00:17:05 - 00:19:27] Jason explains why Particle sued Epic and what the case means for the broader healthcare data ecosystem.
- [00:25:11 - 00:27:11] A key distinction: patient-authorized data use versus unauthorized third-party data harvesting.
- [00:28:34 - 00:32:44] Why patients still can't easily access their own records — and what it would take to change that.
- [00:29:02 - 00:29:41] Information blocking penalties only work when organizations believe the consequences are real.